Stock Events

Stock Events

Active Biotech AB 

€0.01
0
-€0-3.57% Today

Statistics

Day High
0.01
Day Low
0.01
52W High
0.03
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q1 2022
Next
-0
0.33
0.66
1
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BTPC.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap27.06B
Biogen Inc. focuses on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases, overlapping with Active Biotech's focus on neurodegenerative diseases.
Novartis
NVS
Mkt Cap280.79B
Novartis AG engages in the research, development, and marketing of healthcare products, including treatments for neurological conditions similar to those targeted by Active Biotech.
Roche
RHHBY
Mkt Cap332.61B
Roche Holding AG specializes in pharmaceuticals and diagnostics in multiple sclerosis and cancer, directly competing with Active Biotech's research areas.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences, Inc. develops medicines for infectious diseases, liver diseases, cancer, and inflammatory and respiratory diseases, overlapping with Active Biotech's therapeutic areas.
AMGEN
AMGN
Mkt Cap185.74B
Amgen Inc. focuses on human therapeutics, including treatments for illnesses that Active Biotech also targets, such as cancer and inflammatory diseases.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca PLC works on developing products for major disease areas including cancer, which is a key research area for Active Biotech.
Merck
MRK
Mkt Cap276.38B
Merck & Co., Inc. provides healthcare solutions and is involved in the development of pharmaceutical products, including for conditions like cancer, competing with Active Biotech.
Pfizer
PFE
Mkt Cap153.59B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines for oncology, a field Active Biotech is involved in.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.46B
Regeneron Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for serious medical conditions, competing in similar therapeutic areas as Active Biotech.

About

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, a mechanism which is in phase 1 for the treatment of severe inflammatory eye diseases, such as non-infectious uveitis; Tasquinimod, an orally active small molecule immunomodulator that blocks tumor-promoting signals in the bone marrow microenvironment which is in phase I/II for the treatment of hematological cancers, such as myelofibrosis and multiple myeloma; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas ans Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.
Show more...
CEO
Ms. Helen Tuvesson Ph.D.
Employees
5
Country
Sweden
ISIN
SE0001137985

Listings

STU
DE
BTPC.STU
ST
SE
ACTI.ST
F
DE
BTPC.F
LSE
GB
0GQU.LSE

0 Comments

Share your thoughts

FAQ

What is Active Biotech AB stock price today?▼
The current price of BTPC.STU is €0.01 EUR — it has decreased by -3.57% in the past 24 hours. Watch Active Biotech AB stock price performance more closely on the chart.
What is Active Biotech AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Active Biotech AB stocks are traded under the ticker BTPC.STU.
Is Active Biotech AB stock price growing?▼
BTPC.STU stock has fallen by -14.29% compared to the previous week, the month change is a +45.95% rise, over the last year Active Biotech AB has showed a -22.86% decrease.
When is the next Active Biotech AB earnings date?▼
Active Biotech AB is going to release the next earnings report on May 07, 2026.
What were Active Biotech AB earnings last quarter?▼
BTPC.STU earnings for the last quarter are -0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Active Biotech AB have?▼
As of April 29, 2026, the company has 5 employees.
In which sector is Active Biotech AB located?▼
Active Biotech AB operates in the Health & Wellness sector.
When did Active Biotech AB complete a stock split?▼
Active Biotech AB has not had any recent stock splits.
Where is Active Biotech AB headquartered?▼
Active Biotech AB is headquartered in Lund, Sweden.